siRNA, Anti-ACADL, 2'-F/2'-OMe/2'-MOE/Ribo/Backbone-modified(CAT#: SIRGT01022WQ-2OMe)

The product SIRGT01022WQ-2OMe is a type of small interfering RNA (siRNA) that targets ACADL gene and regulates the expression of gene. The siRNA interferes with the expression of ACADL gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001608.3
Alternative Names ACAD4; LCAD
Related Diseases Long-chain acyl-CoA dehydrogenase (LCAD) deficiency, Nonketotic hypoglycemia
Purification HPLC
Target Gene
Gene ID 33
Uniprot ID P28330
Sub Cat Target Species Modification Scale  
SIRGT02022WQ-2F ACADL Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT03022WQ-2MOE ACADL Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT01022WQ-RB ACADL Human Ribo-modified Inquiry
SIRGT02022WQ-BB ACADL Human Backbone-modified Inquiry

Related Products